QUICK ANSWER
CH50 (Complement, Total) measures the overall functional activity of your complement system — a group of serum proteins that coordinate immune defense, inflammation, and clearance of immune complexes.
Normal range: 31–60 U/mL (most laboratories; ranges vary — always use your lab's reference range)
| Result | What it generally means |
|---|---|
| ">60" or "higher than 60" | At or above the upper detection limit — complement system is highly active; most commonly an acute-phase immune or inflammatory response |
| 31–60 U/mL | Normal complement activity |
| Below 31 U/mL | Low complement — may reflect complement consumption (autoimmune disease), complement deficiency, or liver disease |
| Undetectable / 0 | Severely low — may indicate hereditary complement deficiency |
What does ">60" mean on my CH50 result?
Most labs report CH50 using a functional hemolytic assay with an upper detection limit of 60 U/mL. When complement activity is very high, the assay cannot quantify above this threshold and reports the result as ">60" (or "greater than 60," "higher than 60," or ">60 U/mL"). This is not an error — it means your complement system is highly active. In many cases, a result of ">60" reflects an acute immune response, acute inflammation, or normal variation at the upper end of complement activity.
WHAT IS THE CH50 TEST?
The CH50 test measures the total hemolytic complement activity of serum — specifically, the ability of the entire classical complement pathway to lyse (break open) antibody-coated red blood cells. The "50" in CH50 refers to the amount of serum required to lyse 50% of sensitized red blood cells in the standard assay.
What the complement system does:
The complement system is a cascade of more than 20 serum proteins that works alongside antibodies to fight infections, clear immune complexes, and coordinate inflammation. It can be activated through three pathways:
- Classical pathway — triggered by antibody-antigen complexes (the CH50 primarily reflects this pathway)
- Lectin pathway — triggered by carbohydrates on microbial surfaces
- Alternative pathway — triggered directly by microbial surfaces (the AH50 test evaluates this pathway)
Why the CH50 is ordered:
The CH50 is used to screen for:
- Complement deficiency (hereditary or acquired)
- Complement consumption in autoimmune disease (particularly lupus/SLE)
- Monitoring response to SLE therapy
- Evaluating suspected immune complex disease, glomerulonephritis, or cryoglobulinemia
- Recurrent infections with encapsulated bacteria (suggesting complement pathway deficiency)
WHAT DOES ">60" OR "HIGHER THAN 60" MEAN?
This is the most searched question for this marker, and the current page does not address it.
When your CH50 result shows ">60," ">60 U/mL," "higher than 60," or "complement total >60," it means the result exceeded the upper detection limit of the assay — not that there is a specific value above 60. The assay cannot measure precisely above this threshold, so it reports the result as greater-than.
In most cases, a ">60" CH50 result means:
- Your complement system is highly active
- The classical complement pathway is functioning at full capacity
- This is most commonly seen in acute-phase reactions and inflammatory states
Common causes of CH50 ">60" or elevated CH50:
| Cause | Notes |
|---|---|
| Acute-phase inflammatory response | The most common cause — complement proteins are acute-phase reactants that increase during infection, injury, or inflammation |
| Active infection (bacterial, viral) | Complement activation as part of the immune response |
| Ulcerative colitis / IBD | Chronic inflammatory conditions elevate acute-phase complement proteins |
| Sarcoidosis | Associated with elevated complement activity |
| Cancer / malignancy | Certain cancers (lymphoma, leukemia, solid tumors) are associated with elevated complement — see below |
| Acute myocardial infarction | Post-MI inflammatory response can elevate complement |
| Behçet's disease | Vasculitic condition associated with elevated complement |
| Obesity / metabolic syndrome | Chronic low-grade inflammation elevates complement |
Is a high CH50 or ">60" dangerous?
In most cases, no. An elevated CH50 is a sign that the complement system is active — which is appropriate during infection or inflammation. It is far less clinically significant than a low CH50. However, persistently elevated CH50 without an obvious inflammatory trigger may warrant further evaluation.
CH50 AND CANCER
Several queries in the data specifically ask about the cancer connection ("high ch50 and cancer," "cancers associated with high ch50"). This deserves explicit coverage.
Elevated CH50 has been observed in association with various malignancies, including lymphoma (Hodgkin's and non-Hodgkin's), leukemia, sarcoma, and some solid tumors. The mechanism is thought to involve tumor-associated inflammation and acute-phase protein production.
Important caveats:
- Elevated CH50 is not diagnostic for cancer
- Most people with elevated CH50 do not have cancer — the most common causes are infection and inflammation
- Elevated CH50 is not a screening test for cancer
- In the context of cancer, CH50 may be used as one of many markers to monitor disease activity, not to diagnose it
If elevated CH50 is discovered without an obvious inflammatory explanation, a clinician will evaluate the full clinical picture rather than acting on this single marker.
WHAT DOES LOW CH50 MEAN?
Low CH50 (below 31 U/mL on most labs, or below the lab's lower reference limit) is more clinically significant than elevated CH50. It indicates that the complement system is either deficient in one or more components, or that complement is being consumed faster than it is produced.
Two main mechanisms of low CH50:
1. Complement consumption (more common in clinical practice) The complement system is being actively used — typically to fight immune complexes in autoimmune disease. The proteins are "consumed" faster than the liver can replenish them.
2. Complement deficiency (less common) One or more complement proteins are absent due to hereditary deficiency. Because the CH50 requires all classical pathway components to be present and functional, a deficiency in any single component can result in a CH50 of zero or near-zero.
Common causes of low CH50:
| Cause | Notes |
|---|---|
| Systemic lupus erythematosus (SLE) | Classic cause — complement consumption by immune complexes; low CH50 correlates with disease activity |
| Acute and chronic glomerulonephritis | Complement consumption in kidney immune complex disease |
| Cryoglobulinemia | Abnormal proteins consume complement |
| Rheumatoid arthritis | Can cause mild complement consumption |
| Subacute bacterial endocarditis | Complement consumed fighting persistent infection |
| Hemolytic anemias | Red cell destruction activates complement |
| Hereditary complement deficiency | C1q, C2, C4 deficiencies are most common; C2 deficiency is the most prevalent hereditary complement deficiency in Caucasians |
| Liver disease | The liver produces most complement proteins; severe liver disease reduces production |
| Graft rejection | Complement activation during transplant rejection |
| Malnutrition | Reduced protein synthesis affects complement production |
HIGH CH50 BUT NORMAL C3 AND C4
This specific clinical pattern appears in the GSC query data ("high ch50 but normal c3, c4," "ch50 élevé c3, c4 normal") and is worth addressing directly.
When CH50 is elevated but C3 and C4 are normal, it typically suggests:
- Acute-phase elevation — CH50 is elevated because complement proteins are broadly upregulated as acute-phase reactants, but no specific consumption of C3 or C4 has occurred
- Normal physiological variation — the upper end of normal complement activity without pathological complement consumption
- Laboratory threshold effect — a result just above the detection limit (e.g. 62 U/mL being reported as ">60") may reflect minor assay variability
This pattern is generally reassuring compared to a pattern of low C3, low C4, and low CH50, which would suggest active complement consumption (typical of lupus flares).
CH50 IN CONTEXT: CH50 vs C3 AND C4
The CH50 is a functional test of the overall complement pathway. C3 and C4 are individual complement protein concentration tests. Together they provide more diagnostic information than any single test alone.
| Test | What it measures | Most useful for |
|---|---|---|
| CH50 | Functional activity of entire classical pathway | Screening for complement deficiency; overall activity |
| C3 | Concentration of complement protein C3 | Monitoring complement consumption in SLE and glomerulonephritis |
| C4 | Concentration of complement protein C4 | Monitoring classical pathway activity; hereditary C4 deficiency |
Common interpretation patterns:
| Pattern | What it suggests |
|---|---|
| Low CH50 + Low C3 + Low C4 | Active complement consumption — typical of SLE flare, cryoglobulinemia, active glomerulonephritis |
| Low CH50 + Normal C3 + Normal C4 | Possible terminal pathway complement deficiency (C5–C9); also seen in AH50-detectable alternative pathway deficiency |
| Low CH50 + Low C4 + Normal C3 | C4 deficiency or early classical pathway consumption |
| High CH50 + Normal C3 + Normal C4 | Acute-phase elevation; generally benign |
| Normal CH50 + Low C3 or C4 | Partial complement changes; interpret with clinical context |
Complement, Total (CH50)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
Frequently Asked Questions
What does "CH50 higher than 60" or ">60" mean?
What is a normal CH50 range?
What does high CH50 mean?
What does low CH50 mean?
Can high CH50 indicate cancer?
What does it mean if CH50 is high but C3 and C4 are normal?
What is the CH50 test used for?
What is the difference between CH50 and AH50?
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.
-
The complement system as a potential therapeutic target in rheumatic disease
-
Complement System.
-
Complement. First of two parts
-
Complement. Second of two parts